ABBV Abbvie Inc
AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
$155.91 -0.86 (-0.55%)
As of 03/22/2023 12:04:45 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Large cap
GICS sector: Health Care
Industry: Drug Manufacturers—General
Index country: USA
Country of incorporation: USA
IPO date: 12/10/2012
Outstanding shares: 1,769,399,971
Average volume: 7,609,833
Market cap: $276,132,559,474
Current dividend yield: 3.61%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol: B92SR70
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 0.00
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%